KPKwang Min Park

Kwang Min Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kwang Min Park has a total of 84 co-authors. Here are the top co-authors by number of shared publications:

  • Young-Joo Lee

    Division of Hepato-Biliary and Pancreas Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    14 shared publications
  • Shin Hwang

    Department of General Surgery, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, Korea

    13 shared publications
  • Chul-Soo Ahn

    6 shared publications
  • Sung-Gyu Lee

    6 shared publications
  • Jae Hoon Lee

    Division of Hepatobiliary and Pancreas Surgery, Department of Surgery Asan Medical Center 88, Olympic‐Ro 43‐Gil, Songpa‐Gu 138‐736 Seoul Korea

    5 shared publications
  • Ki Byung Song

    Division of Hepatobiliary and Pancreas Surgery, Department of Surgery Asan Medical Center 88, Olympic‐Ro 43‐Gil, Songpa‐Gu 138‐736 Seoul Korea

    5 shared publications

Latest Publications

    • 1 October 2014
      • Vol. 34  (10) , 5621-9

    Postoperative radiotherapy for gallbladder cancer.

    by Yuri Jeong, Jin-Hong Park, Young-Joo Lee, Kwang-Min Park, Shin Hwang, Heung-Moon Chang, Kyu-Pyo Kim, Sang Min Yoon, Nuri Hyun Jung, Jong Hoon Kim

    To evaluate the results of postoperative radiotherapy (PORT) and to identify prognostic factors for gallbladder cancer (GBC). We retrospectively analyzed 86 patients with GBC who underwent potentially curative surgical resection and PORT between November 1993 and December 2009. All patients received three-dimensional conformal radiotherapy and 61 patients (71%) had concurrent chemotherapy. Survival outcomes including locoregional control (LRC), disease-free survival (DFS) and overall survival (OS) rates were analyzed. The median follow-up period was 83 months for surviving patients. The 5-year OS, DFS and LRC rates were 42%, 36% and 73%, respectively. Isolated locoregional recurrence as first failure occurred in seven patients (8%). On multivariate analysis, the postoperative carbohydrate antigen 19-9 (CA 19-9) level was a significant prognostic factor for LRC, DFS and OS. Adjuvant radiotherapy might be an effective treatment in terms of LRC in GBC. Postoperative CA 19-9 might be useful as a surrogate marker for survival.


  • What is the Better Choice for T1b Gallbladder Cancer: Simple Versus Extended Cholecystectomy

    by Jong Hee Yoon, Young Joo Lee, Song Cheol Kim, Jae Hoon Lee, Ki Byung Song, Ji Woong Hwang, Jeong Woo Lee, Dong Joo Lee, Kwang Min Park

    Background: There is debate over whether T1b gallbladder cancer (GBC) should be treated by simple cholecystectomy (SC) or by extended cholecystectomy (EC). The aim of this study is to compare and analyze the results of these two procedures.Patients and methods: The archived medical records of 805 patients with GBC who had undergone surgical resection in Asan Medical Center, or were referred from other hospitals after undergoing surgery, between 1997 and 2010 were retrospectively reviewed. Of these, 85 patients were diagnosed with pathologic stage T1b (muscular layer) GBC. By using propensity scoring, the EC group and the SC group were matched in the proportion of 1:2; so, 54 patients were enrolled in this study.Results: Among the 54 pathologic stage T1b cancer patients, SC was performed in 36 (66.7 %) and EC in 18 (33.4 %). The mean operation time and hospital stay after surgery of the SC group was significantly shorter than in the EC group (83.2 vs. 356.4 min, 7.8 vs. 15.2 days; both p = 0.000). Disease recurrence was noted in four cases (11.1 %), all in the SC group; 50 % of recurred patients experienced recurrence at the lymph node. There was no significant intergroup difference in the 5‐year survival rate (5‐YSR) (88.8 % for SC vs. 93.3 % for EC, p = 0.521).Conclusions: In this study, for stage T1b GBC, both EC and SC offered similar cure rates. However, recurrence is associated with SC and inadequate lymph node dissection (LND). Therefore, EC including regional LND may be justified and preferred because of the possibility of lymph node metastasis and the accurate assessment of stage (LN status), except that the patients have a high risk of operation.


  • Prognosis of stage I pancreatic cancer that was diagnosed pathologically after resection

    by Jong Hee Yoon, Young Joo Lee, Kwang Min Park, Jae Hoon Lee, Ki Byung Song, Ji Woong Hwang, Jeongsu Nam, Jeong Woo Lee, Dong Joo Lee, Song Cheol Kim

  • Laparoscopic spleen-preserving distal pancreatectomy: Comparative study of spleen preservation with splenic vessel resection and splenic vessel preservation

    by Jung Woo Lee, Ki Byung Song, Kwang Min Park, Jae Hoon Lee, Ji Woong Hwang, Jong Hee Yoon, Jeongsu Nam, Dong Joo Lee, Young Joo Lee, Song Cheol Kim

  • Comparative analysis of the short-term clinical outcomes of laparoscopic and open pylorous preserve pancreaticoduodenectomy

    by Ki Byung Song, Kwang-Min Park, Jae Hoon Lee, Ji Woong Hwang, Jong Hee Yoon, Jeongsu Nam, Jung Woo Lee, Dong Ju Lee, Young-Joo Lee, Song Cheol Kim

  • Comparison of outcomes between laparoscopic distal pancreatectomy and open distal pancreatectomy for pancreatic cancer (PDAC)

    by Jeongsu Nam, Ki Byung Song, Young Joo Lee, Kwang Min Park, Jae Honn Lee, Ji Woong Hwang, Jong Hee Yoon, Dong Joo Lee, Jung Woo Lee, Song Cheol Kim


  • Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.

    by Yeon-Dae Kim, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Kwang-Min Park, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, et al.

    Hepatocellular carcinoma (HCC) often recurs after complete surgical resection. Detection of markers of residual circulating cancer cells may predict postoperative HCC recurrence. Human telomerase reverse transcriptase (hTERT) mRNA may be a candidate tumor marker. We prospectively assessed the expression patterns and prognostic value of preoperative peripheral blood hTERT mRNA in patients with HCC undergoing hepatic resection (n=17) or liver transplantation (n=6). As controls, we assessed hTERT mRNA in patients with liver cirrhosis without HCC (n=6) and in living liver donors (n=4). Concentrations of hTERT mRNA were measured by real-time quantitative reverse transcription polymerase chain reaction (RTPCR). No significant difference was observed in the levels of hTERT mRNA between the HCC and control groups. Only alpha-fetoprotein ≥400ng/mL was associated with greater expression levels of hTERT mRNA. At a median follow-up of 30 months, HCC recurred in 10 of 17 resected patients, but in none of the 6 liver transplant recipients. hTERT mRNA concentration was not associated with HCC recurrence after either resection or liver transplantation. Peripheral blood hTERT mRNA concentration is not a likely marker for the diagnosis or prognosis of HCC, especially in patients undergoing resection. Owing to the small number of transplanted patients assessed, the clinical significance of hTERT mRNA concentration was not objectively verified, suggesting the need for a study in larger numbers of HCC patients undergoing liver transplantation.


  • Practical Usefulness of Minor Grooves of the Hepatic Surface for Liver Resection

    by Jae Hoon Lee, Sang Yeup Lee, Dae Wook Hwang, Kwang-Min Park, Young-Joo Lee

    The clinical relevance of grooves of the hepatic surface has not been clearly identified. The aim of the present study was to examine the association of minor grooves and liver segmentations, and to evaluate the usefulness of grooves for liver resection. Between January 2005 and December 2010, 482 patients with hepatic resection for liver disease were included in this study. We performed glissonean pedicle transection methods for hepatic resection to identify sectors or segments of the liver and examined location, size, depth and relationship with intersegmental line of the hepatic grooves. Diaphragmatic grooves were located on anatomical border between right lobe and left lobe and within right anterior sector. The minor grooves were more commonly observed in the right lobe than in the left lobe. The minor grooves between segment V and VI, and segment V and VI were easy to perform monosegmentectomy and right anterior sectionectomy on, respectively. These minor grooves were also helpful to determine the resection margin for non-anatomical resection. Minor grooves were often observed in line with sector or segment, or near to inter-segmental or sectorial border. The anatomical knowledge of hepatic grooves including minor type may be of help for hepatobiliary surgeons and radiologists to understand liver segmentation.


    • 18 March 2011
      • Vol. 57, 1064-8

    Neuroendocrine tumors of the gallbladder: twelve cases in a single institution.

    by Jae-Myeong Lee, Shin Hwang, Sung-Gyu Lee, Young-Joo Lee, Kwang-Min Park, Ki-Hun Kim, Chul-Soo Ahn, Myung-Hwan Kim, Sung-Koo Lee, Myung Wook Kim

    We report a single center experience of 12 cases with neuroendocrine tumor (NET) of the gallbladder. Twelve patients were diagnosed with gallbladder NET between July 1998 and February 2008 and assessed according to the WHO histological classification. Six patients underwent surgical resection and 6 patients underwent nonsurgical treatment. There was one well-differentiated neuroendocrine carcinoma (NEC), 6 poorly differentiated NECs, and 5 mixed exocrine-endocrine carcinomas. All poorly differentiated NECs were small cell carcinomas; four patients had distant metastases at the time of diagnosis; and underwent chemotherapy. All five patients with mixed exocrine-endocrine carcinomas underwent operative treatments. The group with mixed exocrine-endocrine carcinomas and the group with poorly differentiated NECs didn't show a significant difference in overall survival (9.3 months vs. 8.0 months, respectively; p = 0.997). A patient with well-differentiated NEC had portal vein invasion and underwent aggressive curative surgery, but liver metastasis occurred after 1 month and she survived for 9.9 months. NECs of the gallbladder are very aggressive tumors showing poor survival outcomes against current treatments. Further understanding on the clinical and pathologic characteristics of these NETs seems to be necessary to find more effective treatment modalities.